World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
107
Citations
51667
World Ranking
6158
National Ranking
599

Tim Meyer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Tim Meyer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 697 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Tim Meyer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Tim Meyer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 107 D-Index — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Tim Meyer is affiliated with University College London in the United Kingdom. Their primary field of study is Medicine, with a significant focus on Oncology, Hepatology, Epidemiology, Pulmonary and Respiratory Medicine, and Immunology.

The scientist's research centers particularly on hepatocellular carcinoma, cancer immunotherapy, and liver disease. Specific main topics covered in their body of work include:

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer Immunotherapy and Biomarkers
  • Liver Disease Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Ferroptosis and cancer prognosis
  • Colorectal Cancer Treatments and Studies
  • Lung Cancer Research Studies

Tim Meyer's recent published papers include:

  • Hepatocellular carcinoma (2022), The Lancet
  • Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma (2020), Journal of Clinical Oncology
  • Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma (2021), Nature Reviews Gastroenterology & Hepatology
  • Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines (2021), Annals of Oncology
  • Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference (2020), Hepatology

Frequent co-authors with whom Meyer has collaborated include:

  • Richard S. Finn
  • Masatoshi Kudo
  • Josep M. Llovet
  • Arndt Vogel
  • Ann-Lii Cheng

The scientist's publications often appear in the following venues:

  • Journal of Clinical Oncology
  • Journal of Hepatology
  • Annals of Oncology
  • Liver Cancer
  • Clinical Cancer Research

Best Publications

  • Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

    Anthony B. El-Khoueiry;Bruno Sangro;Thomas Yau;Todd S. Crocenzi

  • Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

    John P. Neoptolemos;John P. Neoptolemos;Daniel H. Palmer;Daniel H. Palmer;Paula Ghaneh;Eftychia E. Psarelli

  • Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

    Ghassan K. Abou-Alfa;Tim Meyer;Ann Lii Cheng;Anthony B. El-Khoueiry

  • Straight sprinting is the most frequent action in goal situations in professional football

    Oliver Faude;Thorsten Koch;Tim Meyer

  • Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma

    Richard S. Finn;Masafumi Ikeda;Andrew X. Zhu;Max W. Sung

  • Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies

    Laura Marelli;Rosa Stigliano;Christos Triantos;Marco Senzolo

  • Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

    John K Ramage;A Ahmed;J Ardill;N Bax

  • Lactate threshold concepts: how valid are they?

    Oliver Faude;Wilfried Kindermann;Tim Meyer

  • Hippocampal Plasticity in Response to Exercise in Schizophrenia

    Frank-Gerald Pajonk;Thomas Wobrock;Oliver Gruber;Harald Scherk

  • Sleep and athletic performance: the effects of sleep loss on exercise performance, and physiological and cognitive responses to exercise.

    Hugh H. K. Fullagar;Sabrina Skorski;Rob Duffield;Daniel Hammes

  • Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma

    Josep M. Llovet;Josep M. Llovet;Thierry De Baere;Thierry De Baere;Laura Kulik;Philipp K. Haber

  • A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability

    Manuel Rodríguez-Perálvarez;Tu Vinh Luong;Lorenzo Andreana;Tim Meyer

  • Comparison of Aerobic Exercise, Clomipramine, and Placebo in the Treatment of Panic Disorder

    Andreas Broocks;Borwin Bandelow;Gunda Pekrun;Annette George

  • Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.

    Malte Tiburcy;James E. Hudson;Paul Balfanz;Susanne Schlick

  • A conceptual framework for performance diagnosis and training prescription from submaximal gas exchange parameters--theory and application.

    T Meyer;A Lucia;Conrad P Earnest;W Kindermann

  • Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial.

    Tim Meyer;Tim Meyer;Richard Fox;Yuk Ting Ma;Paul J Ross;Paul J Ross

  • Physical Exercise Prevents Cellular Senescence in Circulating Leukocytes and in the Vessel Wall

    Christian Werner;Tobias Fürster;Thomas Widmann;Janine Pöss

  • Role of tumour markers in monitoring epithelial ovarian cancer.

    T Meyer;G J S Rustin

  • Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis.

    Giacomo Germani;Maria Pleguezuelo;Kurinchi Gurusamy;Tim Meyer

  • A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer.

    L. Kadalayil;R. Benini;L. Pallan;J. O'Beirne

Frequent Co-Authors

Michael Kellmann
Michael Kellmann Ruhr University Bochum
Ghassan K. Abou-Alfa
Ghassan K. Abou-Alfa Memorial Sloan Kettering Cancer Center
Masatoshi Kudo
Masatoshi Kudo Kindai University
Bruno Sangro
Bruno Sangro University of Navarra
Juan W. Valle
Juan W. Valle University of Manchester
Josep M. Llovet
Josep M. Llovet University of Barcelona
Ann-Lii Cheng
Ann-Lii Cheng National Taiwan University
Philip J. Johnson
Philip J. Johnson University of Liverpool
Modesto Orozco
Modesto Orozco University of Barcelona
John A. Hartley
John A. Hartley University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While pursuing a traditional MD in the USA remains highly competitive, there are many alternative medical and healthcare career paths available through online degrees. For those interested in pharmacy, some universities now offer a 3 year online pharmd program, allowing students to earn their Doctor of Pharmacy in a flexible, accelerated format.

Other fields, such as healthcare data management, offer the opportunity to enroll in an online mhi (Master in Health Information Management). This degree prepares you for leadership roles in the fast-growing health informatics sector.

If you're looking for a quicker entry into healthcare, training in billing and coding is a cost-effective option. You can find details on medical billing and coding cost for online certificate and diploma programs.

For nurses aiming to expand their scope of practice, the cheapest online np programs can help you qualify as a nurse practitioner while balancing work and study.

Exploring these online programs can open new career opportunities in the healthcare field, with flexible learning and varying time commitments.

Best Scientists Citing Tim Meyer

Trending Scientists